ICRF has awarded more than $78 million in funding to support over 2,500 grants to outstanding cancer researchers at all leading institutions in Israel as well as collaborative research partnerships between Israeli and North American investigators. Many of our grantees are responsible for major cancer research breakthroughs and discoveries.

Recipient(s)InstitutionGrant TypeResearch TopicsGrant Status
Yitzhak Pilpel, PhD Weizmann Institute of Science Acceleration Grant Computational Biology, Genetics and Genomics, Proteomics and Protein Structures Non-active
Avi Priel, PhD Hebrew University of Jerusalem Brause Family Initiative for Quality of Life Grant Cancer Pain, Clinical and Translational Research, Drug Mechanisms and Development, Inflammation and Cancer, Pain Management, Quality of Life Active
Yoram Reiter, PhD Technion, Israel Institute of Technology Project Grant Animal Modes of Cancer, Blood Cancers, Immunology and Immunotherapy Active
Gad Rennert, MD, PhD Carmel Medical Center ICRF-City of Hope Jacki and Bruce Barron Cancer Research Scholars’ Program Grant Breast Cancer Non-active
Asya Rolls, PhD Technion, Israel Institute of Technology ICRF-Cancer Research Institute Immunotherapy Promise Grant Animal Modes of Cancer, Cancer Metastasis, Immunology and Immunotherapy, Inflammation and Cancer, Model Organisms Active
Rotem Rubinstein, PhD Tel Aviv University Research Career Development Award Blood Cancers, Brain Tumors, Gastrointestinal Cancers, Lung Cancer, Oral Cancers, Skin Cancers, Cancer Metastasis, Immunology and Immunotherapy, Oral Cancer, Proteomics and Protein Structures Active
Maayan Salton, PhD Hebrew University of Jerusalem Research Career Development Award Experimental Therapeutics, Melanoma, RNA Metabolism, Skin Cancer Active
Yardena Samuels, PhD Weizmann Institute of Science ICRF-City of Hope Jacki and Bruce Barron Cancer Research Scholars’ Program Grant Genetics and Genomics, Immunology and Immunotherapy Active
Ronit Satchi-Fainaro, PhD Tel Aviv University Research Professorship Grant Brain Cancer, Breast Cancer, Cancer Metastasis, Immunology and Immunotherapy, Lung Cancer, Nanotechnology Active
Thomas Schultheiss, MD, PhD Technion, Israel Institute of Technology Project Grant Cell Signaling, Intracellular Trafficking, Membrane Biology, Model Organisms, Oncogenesis Active